The European Commission has named research-performing small and
medium-sized enterprises (SMEs) as 'the entrepreneurial stars of
Europe', and hopes to raise €800m of extra funds for them.
UK dosage form specialist BioProgress gave the first insight into
its much-anticipated strategic review yesterday, just over a month
after the departure of former CEO Graham Hind, reports Phil
Taylor.